Pharmaceutical News

RSS

SupaPore VPBA filter enables faster batch processing in veterinary pharmaceutical company

Amazon Filters reports on how its SupaPore VPBA sterile filter cartridge is enabling a veterinary pharmaceutical manufacturer to process its batches faster while still maintaining the quality of the final products.

1 Mar 2018

Aspirin appears to reduce risk of death, hospitalization for people with heart failure and diabetes

For people living with both Type 2 diabetes and heart failure, taking an aspirin each day appears to lower the risk of dying or being hospitalized for heart failure, according to research being presented at the American College of Cardiology's 67th Annual Scientific Session.

28 Feb 2018

Bacteria in humans and animals continue to show high levels of antimicrobial resistance

Bacteria from humans and animals continue to show resistance to antimicrobials, according to a new report published today by the European Food Safety Authority and the European Centre for Disease Prevention and Control.

28 Feb 2018

Diabetes drug use during pregnancy may increase risk of obesity or overweight in children

When women take the common diabetes medication metformin during pregnancy, it may put their children at increased risk of having obesity or overweight.

28 Feb 2018

Failed osteoarthritis drug may help lessen opioid dependence

A new study from Indiana University suggests that a drug proven safe for use in people may prevent opioid tolerance and physical dependence when used in combination with opioid-based pain medications.

27 Feb 2018

Celgene announces regulatory information about investigational compound for relapsing multiple sclerosis

Celgene Corporation today announced that it has received a Refusal to File letter from the United States Food and Drug Administration regarding its New Drug Application for ozanimod in development for the treatment of patients with relapsing forms of multiple sclerosis.

27 Feb 2018

ANU research explores way to reduce unwanted side-effects of common drugs

New research from The Australian National University has drilled down to the molecular level to find similarities across six pharmaceutical drugs used in pain relief, dentist anesthetic, and treatment of epilepsy, in a bid to find a way to reduce unwanted side-effects.

27 Feb 2018

Repurposing leukemia drugs may be effective approach for treating metastatic melanoma patients

Data from a new study led by University of Kentucky Markey Cancer Center researchers shows that repurposing drugs used to treat leukemia has promise for preventing melanoma metastasis.

26 Feb 2018

Researchers find no evidence to support link between hormonal birth control and depression

Women face several options when it comes to birth control, so potential side effects often factor into their decision. Depression is a common concern for many women, but a new study by researchers at The Ohio State University Wexner Medical Center is putting patients at ease. It found there's no evidence to support a link between hormonal birth control and depression.

26 Feb 2018

UC Riverside researchers discover way to halt cancer metastasis

A research team at the University of California, Riverside has discovered a way for chemotherapy drug paclitaxel to target migrating, or circulating, cancer cells, which are responsible for the development of tumor metastases.

23 Feb 2018

Highly sensitive ELISA method for analysis of CET in plasma samples

This article explores the development, full optimization and validation study of a highly sensitive and selective ELISA for determination of cetuximab (CET) in human plasma samples.

23 Feb 2018

Carbon monoxide enhances efficacy of antibiotic against stomach infection

Carbon monoxide can improve the effectiveness of antibiotics, making bacteria more sensitive to antibiotic medication, according to a study led by Georgia State University.

22 Feb 2018

Alfa Laval UltraPure pumps meet the needs of most demanding pharmaceutical applications

Alfa Laval UltraPure pumps are specifically designed for the toughest, most demanding pharmaceutical applications. From high-value, high-risk productions, where every second counts, to reliability and repeatability process-driven productions - whatever your challenge is, there is an UltraPure solution to meet your needs.

From Alfa Laval Corporate AB 22 Feb 2018

Scientists reveal development of improved medicine to fight addiction

Drug addiction continues to plague vast numbers of people across the world, destroying and ending lives, while attempts to develop more effective pharmaceutical addiction treatments continue.

21 Feb 2018

Prophylactic use of haloperidol does not reduce delirium burden

Prophylactic use of the drug haloperidol does not help to prevent delirium in intensive care patients or improve their chances of survival. Therefore, there is no reason anymore to administer the drug as a preventive measure to reduce the burden of delirium.

21 Feb 2018

Researchers provide safety data for common antiparasitic drug used to treat Chagas disease

Benznidazole is one of the two existing antiparasitic drugs for Chagas' disease treatment. However, it is a poorly tolerated drug and its use to treat chronic disease raises safety concerns. Knowledge about its toxicity profile is scarce and mostly based on post-marketing observational studies.

20 Feb 2018

Vitamin D supplementation during pregnancy could protect against childhood obesity

Every parent wants to give their child the best start in life, but what if that consideration needed to happen before the baby was even born?

From BetterYou Ltd 20 Feb 2018

Stanford researchers explore how enzyme changes and becomes antibiotic-resistant

Enzymes are proteins that speed up or catalyze a reaction in living organisms. Bacteria can produce enzymes that make them resistant to antibiotics.

19 Feb 2018

Shot may help reduce risk of shingles

Anyone who has had chickenpox or the chickenpox vaccine is at risk for the painful skin condition herpes zoster, more commonly known as shingles. Both diseases are caused by the varicella-zoster virus, which stays in the body after chickenpox clears and may reactivate later in life.

18 Feb 2018

FDA approves first treatment to reduce risk of NSCLC progression

The U.S. Food and Drug Administration today approved Imfinzi (durvalumab) for the treatment of patients with stage III non-small cell lung cancer (NSCLC) whose tumors are not able to be surgically removed (unresectable) and whose cancer has not progressed after treatment with chemotherapy and radiation (chemoradiation).

18 Feb 2018

Pharmaceutical News

SupaPore VPBA filter enables faster batch processing in veterinary pharmaceutical company

Aspirin appears to reduce risk of death, hospitalization for people with heart failure and diabetes

Bacteria in humans and animals continue to show high levels of antimicrobial resistance

Diabetes drug use during pregnancy may increase risk of obesity or overweight in children

Failed osteoarthritis drug may help lessen opioid dependence

Celgene announces regulatory information about investigational compound for relapsing multiple sclerosis

ANU research explores way to reduce unwanted side-effects of common drugs

Repurposing leukemia drugs may be effective approach for treating metastatic melanoma patients

Researchers find no evidence to support link between hormonal birth control and depression

UC Riverside researchers discover way to halt cancer metastasis

Highly sensitive ELISA method for analysis of CET in plasma samples

Carbon monoxide enhances efficacy of antibiotic against stomach infection

Alfa Laval UltraPure pumps meet the needs of most demanding pharmaceutical applications

Scientists reveal development of improved medicine to fight addiction

Prophylactic use of haloperidol does not reduce delirium burden

Researchers provide safety data for common antiparasitic drug used to treat Chagas disease

Vitamin D supplementation during pregnancy could protect against childhood obesity

Stanford researchers explore how enzyme changes and becomes antibiotic-resistant

Shot may help reduce risk of shingles

FDA approves first treatment to reduce risk of NSCLC progression

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Latest News